Accès à distance ? S'identifier sur le proxy UCLouvain
Ancestim (stem cell factor, SCF) in combination with filgrastim can mobilize sufficient peripheral blood progenitor cells (PBPC) to support high-dose salvage chemotherapy and late intensification in relapsing and refractory aggressive non-Hodgkin's lymphoma. A GELA study.
Primary tabs
| Document type | Communication à un colloque (Conference Paper) – Abstract, Présentation orale avec comité de sélection |
|---|---|
| Publication date | 2003 |
| Language | Anglais |
| Conference | "45th Annual Meeting of the American-Society-of-Hematology", SAN DIEGO (California) (Dec 06-09, 2003) |
| Journal information | "Blood" - Vol. 102, no. 11, p. 415B-415B (2003) |
| Peer reviewed | yes |
| issn | 0006-4971 |
| e-issn | 1528-0020 |
| Publisher | Amer Soc Hematology (Washington) |
| Affiliations |
UCL
- Cliniques universitaires Saint-Luc UCL |
| Links |
| Bibliographic reference | Haioun, C. ; Ferrant, Augustin ; Van Hoof, A. ; Thieblemont, C ; Hulin, C. ; et. al. Ancestim (stem cell factor, SCF) in combination with filgrastim can mobilize sufficient peripheral blood progenitor cells (PBPC) to support high-dose salvage chemotherapy and late intensification in relapsing and refractory aggressive non-Hodgkin's lymphoma. A GELA study..45th Annual Meeting of the American-Society-of-Hematology (SAN DIEGO (California), Dec 06-09, 2003). In: Blood, Vol. 102, no. 11, p. 415B-415B (2003) |
|---|---|
| Permanent URL | http://hdl.handle.net/2078.1/61354 |